Oracle Investment Management as of Dec. 31, 2019
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 17 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 29.4 | $154M | 7.2M | 21.44 | |
| Quidel Corporation | 28.7 | $150M | 2.0M | 75.03 | |
| Biohaven Pharmaceutical Holding | 20.0 | $105M | 1.9M | 54.44 | |
| Dermira | 7.3 | $38M | 2.5M | 15.16 | |
| Accelr8 Technology | 2.8 | $15M | 4.7M | 3.11 | |
| Soleno Therapeutics | 2.2 | $11M | 3.9M | 2.94 | |
| Agenus (AGEN) | 2.1 | $11M | 2.8M | 4.07 | |
| Motus Gi Hldgs Incorporated | 1.7 | $8.7M | 3.8M | 2.29 | |
| Vermillion | 1.5 | $8.0M | 9.8M | 0.81 | |
| Opko Health (OPK) | 1.2 | $6.4M | 4.4M | 1.47 | |
| Pacific Biosciences of California (PACB) | 1.1 | $5.7M | 1.1M | 5.14 | |
| Antares Pharma | 0.6 | $3.2M | 688k | 4.70 | |
| Biolase | 0.5 | $2.8M | 5.2M | 0.55 | |
| AmerisourceBergen (COR) | 0.4 | $2.1M | 25k | 85.04 | |
| Biogen Idec (BIIB) | 0.3 | $1.4M | 4.9k | 296.63 | |
| Contrafect | 0.2 | $932k | 1.5M | 0.62 | |
| Deutsche Bank Ag-registered (DB) | 0.0 | $195k | 25k | 7.80 |
